Scleroderma Associated Myopathy – Treatment
The treatment for Scleroderma Associated Myopathy is still largely unknown because there is not enough information about the disease. The Johns Hopkins Rheumatology Division is working to understand more about this kind of Myopathy. In this video, Dr. Julie Paik, Assistant Professor of Medicine at Johns Hopkins Rheumatology, explains the complicated nature of treating this disease.
In This Video
Dr. Paik is an Assistant Professor of Medicine in the Division of Rheumatology. Dr. Paik’s clinical and research interests are focused on neuromuscular manifestations of autoimmune diseases, particularly in the areas of myositis and scleroderma.